|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07D 401/12 | (2006.01) |
| A61K 31/506 | (2006.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 3371165 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16804956.7 |
| Date of filing the European patent application | 2016-11-04 | |
| (97) | Date of publication of the European application | 2018-09-12 |
| (45) | Date of publication and mention of the grant of the patent | 2022-01-26 |
| (46) | Date of publication of the claims translation | 2022-05-10 |
| (86) | Number | PCT/US2016/060508 |
| Date | 2016-11-04 |
| (87) | Number | WO 2017/079542 |
| Date | 2017-05-11 |
| (30) | Number | Date | Country code |
| 201562250575 P | 2015-11-04 | US | |
| 201662296143 P | 2016-02-17 | US | |
| 201662341189 P | 2016-05-25 | US |
| (72) |
HUCK, Bayard R. , DE
GOODSTAL, Samantha M. , US
GIMMI-MCKIM, Claude , CH
|
| (73) |
Merck Patent GmbH ,
Frankfurter Strasse 250, 64293 Darmstadt,
DE
|
| (74) |
Aušra PAKĖNIENĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | BTK inhibitorius, naudojamas vėžiui gydyti |
| A BTK INHIBITOR FOR USE IN TREATING CANCER |
| Payment date | Validity (years) | Amount | |
| 2025-10-22 | 10 | 231.00 EUR |
| 2026-11-04 |